Health Populi

AUGUST 16, 2019

Employers’ most daunting challenge and uncertainty when it comes to dealing with pharmacy spending is the specialty drug impact — specifically, new million-dollar therapies getting approved by the FDA. Much now depends on the U.S.

Governance 79

Governance Health Care Reform FDA ACA 79

Kaiser Health News

MARCH 15, 2023

La FDA aprueba nuevos medicamentos y sus reformulaciones, pero la orientación que brinda sobre cómo comenzar o removerle la droga a los pacientes podría instar a los médicos a hacerlo con precaución, dijo Kertesz.

FDA 52

FDA COVID-19 Doctors Health Care Reform 52

Kaiser Health News

MARCH 15, 2023

La FDA aprueba nuevos medicamentos y sus reformulaciones, pero la orientación que brinda sobre cómo comenzar o removerle la droga a los pacientes podría instar a los médicos a hacerlo con precaución, dijo Kertesz.

FDA 52

FDA COVID-19 Doctors Health Care Reform 52

Bill of Health

OCTOBER 5, 2023

Food and Drug Administration (FDA) has also begun to consider the regulation of clinical algorithms. In 2021, the FDA released an action plan for the regulation of artificial intelligence and machine learning in medicine, which included supporting the development of methods to evaluate algorithms for bias.

FDA 162

FDA Governance Public Health Hospitals 162

Bill of Health

NOVEMBER 15, 2023

DEA has done little to reduce the appearance of agency capture by the Opioid Treatment Program (OTP) industry, while FDA was years behind the evidence in approving over-the-counter naloxone.

Governance 173

Governance Public Health Telemedicine COVID-19 173

Kaiser Health News

MARCH 15, 2023

He said the new CDC guidance reflects “an extraordinary amount of input” from chronic pain patients and their doctors but doubts it will have much of an impact if the FDA and the Drug Enforcement Administration don’t change how they enforce federal laws.

Doctors 96

Doctors Prescription Drug Pricing FDA COVID-19 96

Kaiser Health News

MARCH 15, 2023

He said the new CDC guidance reflects “an extraordinary amount of input” from chronic pain patients and their doctors but doubts it will have much of an impact if the FDA and the Drug Enforcement Administration don’t change how they enforce federal laws.

Doctors 52

Doctors Prescription Drug Pricing FDA COVID-19 52